EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role and application of chemokine CXCL13 in central nervous system lymphoma

Cuicui Li, Litian Zhang, Qiqi Jin, Haoyun Jiang, Chongyang Wu

Annals of Hematology · 2024

DOI: 10.1007/s00277-023-05560-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Hematology, 2024. Verfasst von Cuicui Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China. Hauptthemen laut MEDLINE: Chemokine CXCL13, Central Nervous System Neoplasms, Lymphoma, Large B-Cell, Diffuse, Tumor Microenvironment. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 94 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Gansu Province, CuiYing Postgraduate Tutor" training program of Lanzhou University Second Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemokine ligand 13 (CXCL13) and its chemokine receptor 5 (CXCR5) both play significant roles in the tumor microenvironment (TME). CXCL13 in cerebrospinal fluid (CSF) has recently been found to have significant diagnostic and prognostic value in primary and secondary central nervous system (CNS) diffuse large B-cell lymphoma (DLBCL), and the CXCL13-CXCR5 axis has been shown to play an important chemotactic role in the TME of CNS-DLBCL. In this review, we first describe the clinical value of CXCL13 in CSF as a prognostic and diagnostic biomarker for CNS-DLBCL. In addition, this review also discusses the specific mechanisms associated with the CXCL13-CXCR5 axis in tumor immunity of primary diffuse large B cell lymphoma of the central nervous system (PCNS-DLBCL) by reviewing the specific mechanisms of this axis in the immune microenvironment of DLBCL and CNS inflammation, as well as the prospects for the use of CXCL13-CXCR5 axis in immunotherapy in PCNS-DLBCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CXCL13Central Nervous System NeoplasmsLymphoma, Large B-Cell, DiffuseTumor MicroenvironmentReceptors, CXCR5HumansBiomarkers, TumorPrognosis

Stichwörter der Autor:innen

CXCL13CXCR5Central nervous system inflammationPrimary central nervous system lymphoma

Substanzen

Chemokine CXCL13CXCL13 protein, humanReceptors, CXCR5CXCR5 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Hematology, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.
  • Department of Hematology, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China. wuchy0909@163.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Gansu Province
  • CuiYing Postgraduate Tutor" training program of Lanzhou University Second Hospital
  • CuiYing Postgraduate Tutor” training program of Lanzhou University Second Hospital

Zitieren

APA

Li, C., Zhang, L., Jin, Q., Jiang, H., & Wu, C. (2024). Role and application of chemokine CXCL13 in central nervous system lymphoma. Annals of Hematology. https://doi.org/10.1007/s00277-023-05560-4

Vancouver

Li C, Zhang L, Jin Q, Jiang H, Wu C. Role and application of chemokine CXCL13 in central nervous system lymphoma. Annals of Hematology. 2024. doi:10.1007/s00277-023-05560-4

BibTeX
@article{Li2024,
  author = {Li, Cuicui and Zhang, Litian and Jin, Qiqi and Jiang, Haoyun and Wu, Chongyang},
  title = {Role and application of chemokine CXCL13 in central nervous system lymphoma},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-023-05560-4}
}
Kostenlos starten →